Stocks›Healthcare

Manipal Health Enterprises Limited

MANIPALHOS · NSE · Healthcare · As of 8 Nov 2026

₹658.40

+₹11.70 (+1.81%)(1D)

₹597.00Since listing range₹815.00

Market Cap

₹86,604 Cr

P/E (Sector)

85.4 (32.3)

P/B Ratio

—

Dividend Yield

—

ROE

10.4%

Debt / Equity

1.20

Anvest Score

40/100

Valuation

47/100

Quality

42/100

Growth

30/100

Health

38/100

Momentum

—

Omitted

Valuation
47
Quality
42
Growth
30
Health
38
Momentum
—

AI Company ProfileFiling-backed

AI Snapshot

The offer was priced at Rs 590 per equity share, leaving 1,315,377,202 equity shares outstanding after the offer. Company facts on this page are read from the offer document registered with SEBI; operating history will build up from the company's own filings from its first reporting quarter onwards.

HospitalFounded:2010CEO/MD:Dilip JoseHQ:The Annexe, #98/2, Rustom Bagh, HAL Airport Road, Bengaluru 560 017, Karnataka, India

Business profile as of period ended 16 Oct 2026

Business at a Glance

Operates in a competitive healthcare service environment.
Customer base is wide with no single customer dependency.

Revenue growth: +25.4%FY26 growth
PAT growth: -15.3%FY26 growth
CFO / PAT: 2.27×FY26

What Looks Strong

Cash FlowOperating cash flow was 2.27× total net profit in FY26.

What to Watch

EarningsNet profit fell about 15% in FY26 (consolidated: ₹1,082 cr → ₹917 cr). Watch margins and one-off items in the next filing.
ValuationThe shares trade at 83× trailing earnings; the multiple assumes sustained high growth and is sensitive to any slowdown.
HistoryShort public market track record with limited historical filing cycles.

Loading company profile…

Fundamentals

P/E Ratio (TTM)

85.4

Sector median P/E

32.29

P/B Ratio

—

Sector median P/B

4.4

EPS (TTM)

₹7.71

Market Cap

₹86,604 Cr

ROE

10.42%

ROCE

10.55%

Profit Margin

8.71%

Debt/Equity

1.2

Manipal Health Enterprises Limited FAQs

3 topics

Expand

What does the Manipal Health Enterprises Limited (MANIPALHOS) stock page cover?

Manipal Health Enterprises Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.

What are the current headline metrics for MANIPALHOS?

Manipal Health Enterprises Limited is currently shown with a delayed price near ₹658.4, P/E 85.4, and ROE 10.42%.

Does the MANIPALHOS page provide investment advice?

No. The MANIPALHOS page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Keep exploring